77 related articles for article (PubMed ID: 6233622)
1. A double blind study of imipramine versus zimelidine in treatment of obsessive compulsive neurosis.
Prasad A
Pharmacopsychiatry; 1984 Mar; 17(2):61-2. PubMed ID: 6233622
[TBL] [Abstract][Full Text] [Related]
2. [A cross-over treatment of obsessive-compulsive neurosis with imipramine and chlorimipramine].
Lei BS
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1986 Oct; 19(5):275-8. PubMed ID: 3556093
[No Abstract] [Full Text] [Related]
3. Obsessive-compulsive disorder and serotonin: is there a connection?
Insel TR; Mueller EA; Alterman I; Linnoila M; Murphy DL
Biol Psychiatry; 1985 Nov; 20(11):1174-88. PubMed ID: 2413912
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder.
McDougle CJ; Goodman WK; Leckman JF; Barr LC; Heninger GR; Price LH
J Clin Psychopharmacol; 1993 Oct; 13(5):354-8. PubMed ID: 8227493
[TBL] [Abstract][Full Text] [Related]
5. Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder.
Chouinard G; Goodman W; Greist J; Jenike M; Rasmussen S; White K; Hackett E; Gaffney M; Bick PA
Psychopharmacol Bull; 1990; 26(3):279-84. PubMed ID: 2274626
[TBL] [Abstract][Full Text] [Related]
6. Clomipramine and obsessive compulsive disorder: a placebo-controlled double-blind study of 32 patients.
Greist JH; Jefferson JW; Rosenfeld R; Gutzmann LD; March JS; Barklage NE
J Clin Psychiatry; 1990 Jul; 51(7):292-7. PubMed ID: 2195006
[TBL] [Abstract][Full Text] [Related]
7. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.
Freeman CP; Trimble MR; Deakin JF; Stokes TM; Ashford JJ
J Clin Psychiatry; 1994 Jul; 55(7):301-5. PubMed ID: 8071291
[TBL] [Abstract][Full Text] [Related]
8. Treatment of childhood obsessive compulsive disorder with clomipramine and desmethylimipramine: a double-blind crossover comparison.
Leonard H; Swedo S; Rapoport JL; Coffey M; Cheslow D
Psychopharmacol Bull; 1988; 24(1):93-5. PubMed ID: 3290954
[No Abstract] [Full Text] [Related]
9. Efficacy and tolerance of femoxetine and imipramine in the treatment of depressive states. A randomized, double-blind study.
Suominen J; Tamminen T; Elosuo R; Manniche PM
Pharmacopsychiatry; 1988 Sep; 21(5):238-44. PubMed ID: 3067246
[TBL] [Abstract][Full Text] [Related]
10. Preliminary results from a multicenter trial of clomipramine in obsessive-compulsive disorder.
DeVeaugh-Geiss J; Landau P; Katz R
Psychopharmacol Bull; 1989; 25(1):36-40. PubMed ID: 2672070
[TBL] [Abstract][Full Text] [Related]
11. Imipramine and placebo in the treatment of obsessive-compulsives: their effect on depression and on obsessional symptoms.
Foa EB; Steketee G; Kozak MJ; Dugger D
Psychopharmacol Bull; 1987; 23(1):8-11. PubMed ID: 3602334
[No Abstract] [Full Text] [Related]
12. Do serotonin uptake inhibitors decrease smoking? Observations in a group of heavy drinkers.
Sellers EM; Naranjo CA; Kadlec K
J Clin Psychopharmacol; 1987 Dec; 7(6):417-20. PubMed ID: 2963034
[TBL] [Abstract][Full Text] [Related]
13. A controlled trial of lithium augmentation in fluvoxamine-refractory obsessive-compulsive disorder: lack of efficacy.
McDougle CJ; Price LH; Goodman WK; Charney DS; Heninger GR
J Clin Psychopharmacol; 1991 Jun; 11(3):175-84. PubMed ID: 1820757
[TBL] [Abstract][Full Text] [Related]
14. A double-blind comparative trial of zimelidine, amitriptyline, and placebo in patients with mixed anxiety and depression.
Amsterdam JD; Case WG; Csanalosi E; Singer M; Rickels K
Pharmacopsychiatry; 1986 May; 19(3):115-9. PubMed ID: 2941771
[TBL] [Abstract][Full Text] [Related]
15. Effect of a selective serotonin uptake inhibitor in agoraphobia with panic attacks. A double-blind comparison of zimeldine, imipramine and placebo.
Evans L; Kenardy J; Schneider P; Hoey H
Acta Psychiatr Scand; 1986 Jan; 73(1):49-53. PubMed ID: 2938422
[TBL] [Abstract][Full Text] [Related]
16. [A double-blind trial of chlorimipramine and doxepin in obsessive-compulsive neurosis].
Cui YH
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1986 Oct; 19(5):279-81. PubMed ID: 3556094
[No Abstract] [Full Text] [Related]
17. An integrated approach to treatment of obsessive compulsive disorder.
Greist JH
J Clin Psychiatry; 1992 Apr; 53 Suppl():38-41. PubMed ID: 1532963
[TBL] [Abstract][Full Text] [Related]
18. An open clinical trial of fluoxetine in the treatment of obsessive-compulsive disorder.
Fontaine R; Chouinard G
J Clin Psychopharmacol; 1986 Apr; 6(2):98-101. PubMed ID: 3517083
[TBL] [Abstract][Full Text] [Related]
19. A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a norepinephrine uptake inhibitor, in endogenous depression: clinical and biochemical findings.
Aberg-Wistedt A; Ross SB; Jostell KG; Sjöquist B
Adv Biochem Psychopharmacol; 1984; 39():439-47. PubMed ID: 6205564
[No Abstract] [Full Text] [Related]
20. D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder.
Storch EA; Merlo LJ; Bengtson M; Murphy TK; Lewis MH; Yang MC; Jacob ML; Larson M; Hirsh A; Fernandez M; Geffken GR; Goodman WK
Int Clin Psychopharmacol; 2007 Jul; 22(4):230-7. PubMed ID: 17519647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
